LLY
Eli Lilly·NYSE
--
--(--)
--
--(--)
LLY fundamentals
Eli Lilly (LLY) Revenue Breakdown: Q4 2025 Business & Regional Performance
Eli Lilly (LLY) reported total revenue of 13.27B USD in Q4 2025, with its core business segment Mounjaro contributing 55.82%. Regionally, United States remained the largest market, accounting for 64.20% of total revenue. Explore Eli Lilly's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Eli Lilly (LLY) reported total revenue of 13.27B USD in Q4 2025, with its core business segment Mounjaro contributing 55.82%. Regionally, United States remained the largest market, accounting for 64.20% of total revenue. Explore Eli Lilly's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Eli Lilly's revenue and profit?What is the market's earnings forecast for Eli Lilly next quarter?What guidance did Eli Lilly's management provide for the next earnings period?What were the key takeaways from Eli Lilly’s earnings call?What does Eli Lilly do and what are its main business segments?What is the revenue and EPS growth rate for Eli Lilly year over year?What were the key takeaways from Eli Lilly's earnings call?Did Eli Lilly beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
